01 — At a Glance
The Murugappa Sugar ATM With a ₹35,000 Cr Fertilizer Jackpot
- 52-Week High / Low₹1,247 / ₹687
- Q3 FY26 Revenue₹10,316 Cr
- Q3 FY26 PAT₹437 Cr
- TTM EPS₹66.9
- Annualised EPS (Q1–Q3 Avg × 4)₹67.68
- Book Value / Share₹486
- Price to Book1.68x
- Cane Recovery (Dec 2025)11.19%
- Distillery Sales407 LL
- Coromandel Stake Value~₹35,000 Cr
Flash Summary: EID Parry Q3 FY26 revenue jumped 18.3% YoY to ₹10,316 Cr with cane recovery at 11.19% (vs 7.78% YoY). Distillery volumes steady at 407 lakh litres. PAT ₹437 Cr. Yet Crisil downgraded to AA-/Stable, FY25 impairment of ₹427 Cr hit the books, and CPG took a ₹10 Cr channel-correction hit. Stock at ₹816, returned –21.8% in 3 months, trades at 13.7x P/E while holding 56% of Coromandel (market value ~₹35,000 Cr). The sugar business is the side dish; the fertilizer stake is the main course.
02 — Introduction
The Holding Company That Pretends to Be a Sugar Mill
Picture this: you own a sugar company that crushes cane, makes ethanol, sells power and even peddles jaggery in retail packs. Sounds straightforward. Except EID Parry is also the proud owner of 56% of Coromandel International — India’s largest private NPK fertiliser player. That stake alone is worth roughly ₹35,000 Cr today. The operating sugar + distillery business? Meh. The holding-company premium? Massive.
Q3 FY26 delivered the usual sugar drama: better crushing days, stellar 11.19% recovery, but landed cane cost up to ₹4,122/MT. Distillery chugged along at 407 lakh litres. Consumer Products Group (CPG) took a deliberate channel reset and booked ₹10 Cr impairment. Refinery losses narrowed sharply. And the stock? Still sulking at 13.7x P/E while the market keeps staring at the sugar cycle instead of the Coromandel jackpot.
The Feb 2026 concall was pure Murugappa honesty: policy paralysis on MSP and ethanol pricing, El Niño risk, and a conscious CPG reset that will finish by Q4. Translation — the sugar business is policy-dependent, but the holding value is structural. At current valuations, you’re basically buying Coromandel at a discount through the back door.
Concall Note (Feb 2026): “Q3 is structurally weak… Tamil Nadu season starts late… December, Jan, Feb more profitable.” Management also confirmed CPG correction ends Q4 and new FMCG categories (millets, dals, ready-to-cook) will be announced in Q1. Inorganic growth in non-sweetener FMCG is explicitly on the table.
03 — Business Model: WTF Do They Even Do?
They Crush Cane, Make Booze, Sell Power… and Own a Fertiliser Empire
EID Parry is the Murugappa Group’s sugar vehicle with six plants (40,800 TCD capacity), five distilleries (582 KLPD post-expansion), 140 MW co-gen and a 3,000 TPD refinery through wholly-owned Parry Sugar Refinery India Pvt Ltd. They also run a tiny nutraceuticals (spirulina) business and a fast-growing Consumer Products Group pushing Parry’s Vita sugar, jaggery, millets and dals across 1.1 lakh+ outlets (target 2 lakh by 2025).
But the real game is the 56% stake in Coromandel International — the largest private NPK and single super phosphate player in India. That stake alone is worth more than EID Parry’s entire market cap on some days. The sugar + ethanol business is volatile and policy-driven; the holding-company structure is the moat.
Revenue mix FY24 (pre-Q3 update): Nutrient & Allied (via Coromandel) 67%, Sugar 21%, Crop Protection 8%, Distillery 2%, Co-gen 1%, Nutraceuticals 1%. Domestic 81%, exports 19%. Management wants to grow non-sugar revenues to reduce commodity risk. Translation: they know sugar is a government lottery ticket and are quietly building the real business around it.
Sugar21%of revenue
Distillery2%but growing fast
Coromandel Stake56%₹35k Cr value
CPG Outlets1.1 lakh+target 2 lakh
Fun fact: Every time you buy Parry sugar or jaggery in South India, you’re indirectly funding a fertilizer giant. The sugar business pays the bills; the Coromandel stake pays the dividends (when they declare any).
💬 At 13.7x P/E with a ₹35,000 Cr Coromandel stake, are you buying the sugar mill or the holding company discount? Drop your take in the comments.
04 — Financials Overview
Q3 FY26: Recovery Up, Volumes Steady, CPG Reset On
Result type: Quarterly Results | Q3 FY26 EPS: ₹13.05 | Q1–Q3 Avg EPS: (₹13.85 + ₹23.86 + ₹13.05)/3 = ₹16.92 | Annualised EPS: ₹67.68
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 10,316 | 8,720 | 11,624 | +18.3% | -11.2% |
| Operating Profit | 835 | 694 | 1,198 | +20.3% | -30.3% |
| PAT | 437 | 416 | 766 | +5.0% | -42.9% |
| EPS (₹) | 13.05 | 10.97 | 23.86 | +19.0% | -45.3% |
P/E Check: TTM EPS ₹66.9. CMP ₹816. P/E 13.7x. Industry median 22.1x. EID Parry trades at a 38% discount. The market is still pricing the sugar volatility and FY25 impairment instead of the ₹35,000 Cr Coromandel holding and improving distillery scale. Classic Murugappa — solid business, sleepy multiple.
💬 With recovery at 11.19% and distillery at 407 LL, why is the market still treating EID Parry like a pure sugar cyclical? Policy risk or Coromandel discount? Comments open.
05 — Valuation: Fair Value Range
What Is This Holding Company Actually Worth?
Join 10,000+ investors who read this every week.
